Search Results 1221-1230 of 19039 for Neutrophil

1. The Appropriate Timing of CT Abdomen in Febrile Neutropenic Patient - Mayo Clinic

   About this study. The purpose of this study is to develop a highly sensitive clinical prediction rule to identify patients with neutropenic fever who are at ...

2. Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

   Within 2 weeks prior to initiation of study treatment: Absolute neutrophil count >= 1,500/mcL. Within 2 weeks prior to initiation of study treatment ...

3. Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary - Mayo Clinic

   Absolute Neutrophil Count (ANC) ≥ 900 K/mm3; Hemoglobin (Hgb) ≥ 8.5 g/dL without transfusion or EPO dependency (≤ 7 days prior to assessment); Platelets ...

4. Lenalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Absolute neutrophil count ≥ 1000μL; (Untransfused) platelet count ≥ 50000/μL; Hemoglobin ≥ 8.0 g/dL; Relapsed myeloma that previously became refractory to ...

5. XmAb®20717 Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

   * Absolute neutrophil count ≤ 1.7 × 109 for subjects who will receive cabazitaxel; \< 1.0 × 109/L for all others * Aspartate aminotransferase at screening ...

6. Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1,800 cells/mm^3; Platelets ≥ 100,000 cells/mm^3; Hemoglobin ≥ 10.0 g/dl (note: the use of transfusion or other ...

7. A pivotal study of derazantinib in patients with inoperable or advanced intrahepatic cholangiocarcinoma and FGFR2 gene fusions or FGFR2 gene mutations or amplifications - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1.5 × 10^9/L;; Platelet count ≥ 75 × 10^9/L;; International normalized ratio (INR) 0.8 to upper limit of normal (ULN) or ...

8. Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1.5 x 10^9/L; Hemoglobin ≥ 9 g/dL; Platelets ≥ 100 x 10^9/L; Albumin ≥ 2.5 g/dL; Total bilirubin ≤ 1.5 x institutional ...

9. Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib - Mayo Clinic

   Absolute neutrophil count ≥ 1000/mL;; Untransfused platelet count ≥ 75000/mL;; Hemoglobin ≥ 8.0 g/dL;; Total bilirubin ≤ 1.5 x the upper limit of the ...

10. Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1,800/mm^3*; Platelet count ≥ 100,000/mm^3*; Hemoglobin ≥ 8.0 g/dL (transfusion or other intervention to achieve level ...